Clancy Paul J is a director of Xilio Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Mar 24 | INCY Incyte | Common Stock | Grant | Acquire A | No | Yes | 56.97 | 403 | 22.96 k | 15,785 |
29 Dec 23 | INCY Incyte | Common Stock | Grant | Acquire A | No | Yes | 62.79 | 412 | 25.87 k | 15,382 |
29 Sep 23 | INCY Incyte | Common Stock | Grant | Acquire A | No | Yes | 57.77 | 379 | 21.89 k | 14,970 |
14 Jun 23 | INCY Incyte | Common Stock | Grant | Acquire A | No | No | 0 | 2,505 | 0.00 | 14,211 |
14 Jun 23 | INCY Incyte | NQSO Common Stock | Grant | Acquire A | No | No | 61.44 | 11,294 | 693.90 k | 11,294 |
12 Jun 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.8 | 13,200 | 36.96 k | 13,200 |